Skip to main content

BIO

Bio-Rad Laboratories, Inc.

Company with tickers: BIO, BIO-B

CIK
12208
CUSIP
090572207
Shares Outstanding
21,700,560
13F Activity (30d)
140 filings 133 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$500,000,000
as of 2025-12-31
Remaining Authorization
$284,600,000
as of 2025-12-31
Fiscal Year Ended Cash Spent
2026-03-31 YTD $47,800,000
2025-12-31 $295,500,000
2024-12-31 $203,600,000
2023-12-31 $428,700,000
2022-12-31 $215,700,000
2021-12-31 $49,998,000
2020-12-31 $100,004,000
2019-12-31 $28,000,000
2018-12-31 $48,912,000
2017-12-31 $2,920,000
2016-12-31 $0
2015-12-31 $0
2014-12-31 $0
2013-12-31 $0
2012-12-31 $101,000
2011-12-31 $0
2010-12-31 $0

Recent quarters

Quarter Ended Cash Spent
2026-03-31 $47,800,000
2025-12-31 $0 Δ
2025-09-30 $53,400,000 Δ
2025-06-30 $140,200,000 Δ
2025-03-31 $101,900,000
2024-12-31 $0 Δ
2024-09-30 $97,900,000 Δ
2024-06-30 $101,000,000 Δ
2024-03-31 $4,700,000
2023-12-31 $199,972,000 Δ
2023-09-30 $21,321,000 Δ
2023-06-30 $207,407,000 Δ